SCHEMBL4252113

SCHEMBL4252113

CN(C)c1c(Cl)cccc1CN

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.57
DPP4 P27487 2/20 0.47
AOC3 Q16853 1/20 0.43
TAAR1 Q96RJ0 4/20 0.42
NISCH Q9Y2I1 1/20 0.38
PRMT3 O60678 1/20 0.37
CARM1 Q86X55 1/20 0.37
PRMT6 Q96LA8 1/20 0.37
PRMT8 Q9NR22 1/20 0.37
IDO1 P14902 3/20 0.37
PYCR1 P32322 1/20 0.37
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16746561 0.78 CYP1A2 (0.43) PNMTAOC3TAAR1NISCHCYP1A2
SCHEMBL11435277 0.78 PNMT (0.39) PNMTDPP4AOC3SLC6A2SLC6A4
SCHEMBL4487257 0.73 PNMT (0.54) PNMTDPP4AOC3TAAR1IDO1
SCHEMBL42705 0.73 PNMT (1.00) PNMTDPP4TAAR1IDO1
SCHEMBL1636099 0.72 PNMT (0.64) PNMTDPP4AOC3TAAR1IDO1
SCHEMBL3787574 0.72 ALDH1A1 (0.58) AOC3CYP1A2CYP3A4
Ethane SCHEMBL11112292 0.72 PNMT (0.90) PNMTDPP4AOC3TAAR1IDO1
Hydrochloric Acid SCHEMBL9035217 0.72 PNMT (0.95) PNMTDPP4TAAR1IDO1CYP1A2
Hydrochloric Acid SCHEMBL7895633 0.71 PNMT (0.61) PNMTDPP4AOC3TAAR1IDO1
SCHEMBL9299 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190125753-A1 COMPOUNDS AND METHODS FOR INCREASING HEMATOPOIESIS UNIV SOUTHERN CALIFORNIA (US) 2019-05-02 US disclosed
WO-2017184808-A1 COMPOUNDS AND METHODS FOR INCREASING HEMATOPOIESIS UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2017-10-26 WO disclosed
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION CHOONGWAE PHARMA CORPORATION (KR) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215783-A1 COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION MYLK2, TNNC1, MYH2 PNMT 2994/4885DPP4 3231/4885AOC3 2907/4885
US-20190125753-A1 COMPOUNDS AND METHODS FOR INCREASING HEMATOPOIESIS CTNNB1, CTNNA1, HCLS1 PNMT 4139/4885DPP4 4702/4885AOC3 2984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.